203 related articles for article (PubMed ID: 31409545)
1. Metabolic profiling of human gliomas assessed with NMR.
Lee JE; Jeun SS; Kim SH; Yoo CY; Baek HM; Yang SH
J Clin Neurosci; 2019 Oct; 68():275-280. PubMed ID: 31409545
[TBL] [Abstract][Full Text] [Related]
2. Metabolic Variations between Low-Grade and High-Grade Gliomas-Profiling by
Jothi J; Janardhanam VA; Krishnaswamy R
J Proteome Res; 2020 Jun; 19(6):2483-2490. PubMed ID: 32393032
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypes.
Zhao H; Heimberger AB; Lu Z; Wu X; Hodges TR; Song R; Shen J
Oncotarget; 2016 Apr; 7(15):20486-95. PubMed ID: 26967252
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of glutamate with 2-hydroxyglutarate in magnetic resonance spectroscopy for IDH1 mutant glioma.
Nagashima H; Tanaka K; Sasayama T; Irino Y; Sato N; Takeuchi Y; Kyotani K; Mukasa A; Mizukawa K; Sakata J; Yamamoto Y; Hosoda K; Itoh T; Sasaki R; Kohmura E
Neuro Oncol; 2016 Nov; 18(11):1559-1568. PubMed ID: 27154922
[TBL] [Abstract][Full Text] [Related]
5. In vivo Metabolic Profiles as Determined by
Wenger KJ; Hattingen E; Franz K; Steinbach J; Bähr O; Pilatus U
Clin Neuroradiol; 2019 Mar; 29(1):27-36. PubMed ID: 28983683
[TBL] [Abstract][Full Text] [Related]
6. MR spectroscopy for in vivo assessment of the oncometabolite 2-hydroxyglutarate and its effects on cellular metabolism in human brain gliomas at 9.4T.
Bisdas S; Chadzynski GL; Braun C; Schittenhelm J; Skardelly M; Hagberg GE; Ethofer T; Pohmann R; Shajan G; Engelmann J; Tabatabai G; Ziemann U; Ernemann U; Scheffler K
J Magn Reson Imaging; 2016 Oct; 44(4):823-33. PubMed ID: 26970248
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of 2-hydroxyglutarate magnetic resonance spectroscopy in newly diagnosed brain mass and suspected recurrent gliomas.
Zhou M; Zhou Y; Liao H; Rowland BC; Kong X; Arvold ND; Reardon DA; Wen PY; Lin AP; Huang RY
Neuro Oncol; 2018 Aug; 20(9):1262-1271. PubMed ID: 29438510
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic signature of brain cancer.
Pandey R; Caflisch L; Lodi A; Brenner AJ; Tiziani S
Mol Carcinog; 2017 Nov; 56(11):2355-2371. PubMed ID: 28618012
[TBL] [Abstract][Full Text] [Related]
9. Metabonomic signature analysis in plasma samples of glioma patients based on (1)H-nuclear magnetic resonance spectroscopy.
Kelimu A; Xie R; Zhang K; Zhuang Z; Mamtimin B; Sheyhidin I
Neurol India; 2016; 64(2):246-51. PubMed ID: 26954801
[TBL] [Abstract][Full Text] [Related]
10. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy.
Kinoshita Y; Yokota A
NMR Biomed; 1997 Jan; 10(1):2-12. PubMed ID: 9251109
[TBL] [Abstract][Full Text] [Related]
11. Potential of MR spectroscopy for assessment of glioma grading.
Bulik M; Jancalek R; Vanicek J; Skoch A; Mechl M
Clin Neurol Neurosurg; 2013 Feb; 115(2):146-53. PubMed ID: 23237636
[TBL] [Abstract][Full Text] [Related]
12. Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma.
de la Fuente MI; Young RJ; Rubel J; Rosenblum M; Tisnado J; Briggs S; Arevalo-Perez J; Cross JR; Campos C; Straley K; Zhu D; Dong C; Thomas A; Omuro AA; Nolan CP; Pentsova E; Kaley TJ; Oh JH; Noeske R; Maher E; Choi C; Gutin PH; Holodny AI; Yen K; DeAngelis LM; Mellinghoff IK; Thakur SB
Neuro Oncol; 2016 Feb; 18(2):283-90. PubMed ID: 26691210
[TBL] [Abstract][Full Text] [Related]
13. (1)H NMR based metabolomic profiling revealed doxorubicin-induced systematic alterations in a rat model.
Niu QY; Li ZY; Du GH; Qin XM
J Pharm Biomed Anal; 2016 Jan; 118():338-348. PubMed ID: 26595282
[TBL] [Abstract][Full Text] [Related]
14. What Does Reduced FDG Uptake Mean in High-Grade Gliomas?
Bund C; Lhermitte B; Cicek AE; Ruhland E; Proust F; Namer IJ
Clin Nucl Med; 2019 Dec; 44(12):936-942. PubMed ID: 31524681
[TBL] [Abstract][Full Text] [Related]
15. Nuclear magnetic resonance metabolic fingerprint of bevacizumab in mutant IDH1 glioma cells.
Mesti T; Bouchemal N; Banissi C; Triba MN; Marbeuf-Gueye C; Cemazar M; Moyec LL; Carpentier AF; Savarin P; Ocvirk J
Radiol Oncol; 2018 Nov; 52(4):392-398. PubMed ID: 30511933
[TBL] [Abstract][Full Text] [Related]
16. Conditions for (13)C NMR detection of 2-hydroxyglutarate in tissue extracts from isocitrate dehydrogenase-mutated gliomas.
Pichumani K; Mashimo T; Baek HM; Ratnakar J; Mickey B; DeBerardinis RJ; Maher EA; Bachoo RM; Malloy CR; Kovacs Z
Anal Biochem; 2015 Jul; 481():4-6. PubMed ID: 25908561
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of 2-hydroxyglutarate in gliomas correlates with survival: a study by 3.0-tesla magnetic resonance spectroscopy.
Natsumeda M; Igarashi H; Nomura T; Ogura R; Tsukamoto Y; Kobayashi T; Aoki H; Okamoto K; Kakita A; Takahashi H; Nakada T; Fujii Y
Acta Neuropathol Commun; 2014 Nov; 2():158. PubMed ID: 25376594
[TBL] [Abstract][Full Text] [Related]
18. Characterization of dysregulated glutamine metabolism in human glioma tissue with
Ekici S; Risk BB; Neill SG; Shu HK; Fleischer CC
Sci Rep; 2020 Nov; 10(1):20435. PubMed ID: 33235296
[TBL] [Abstract][Full Text] [Related]
19. MR Imaging-derived Oxygen Metabolism and Neovascularization Characterization for Grading and IDH Gene Mutation Detection of Gliomas.
Stadlbauer A; Zimmermann M; Kitzwögerer M; Oberndorfer S; Rössler K; Dörfler A; Buchfelder M; Heinz G
Radiology; 2017 Jun; 283(3):799-809. PubMed ID: 27982759
[TBL] [Abstract][Full Text] [Related]
20. Malignancy-associated metabolic profiling of human glioma cell lines using 1H NMR spectroscopy.
Shao W; Gu J; Huang C; Liu D; Huang H; Huang Z; Lin Z; Yang W; Liu K; Lin D; Ji T
Mol Cancer; 2014 Aug; 13():197. PubMed ID: 25163530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
